Estée Lauder Companies (NYSE:EL – Get Free Report) had its price target dropped by research analysts at Deutsche Bank Aktiengesellschaft from $98.00 to $75.00 in a note issued to investors on Monday, Benzinga reports. The brokerage currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential upside of 10.12% from the company’s current price.
EL has been the subject of a number of other reports. Raymond James downgraded Estée Lauder Companies from a “strong-buy” rating to a “market perform” rating in a research report on Monday, July 22nd. TD Cowen dropped their price objective on Estée Lauder Companies from $95.00 to $70.00 and set a “hold” rating for the company in a research note on Friday. B. Riley assumed coverage on Estée Lauder Companies in a research note on Tuesday, September 10th. They set a “neutral” rating and a $95.00 price target for the company. Evercore ISI dropped their target price on Estée Lauder Companies from $180.00 to $130.00 and set an “outperform” rating for the company in a report on Tuesday, August 20th. Finally, Royal Bank of Canada dropped their target price on Estée Lauder Companies from $131.00 to $100.00 and set an “outperform” rating for the company in a report on Friday. Nineteen investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $102.10.
View Our Latest Analysis on EL
Estée Lauder Companies Stock Up 2.3 %
Estée Lauder Companies (NYSE:EL – Get Free Report) last released its earnings results on Thursday, October 31st. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. Estée Lauder Companies had a return on equity of 17.31% and a net margin of 1.31%. The firm had revenue of $3.36 billion during the quarter, compared to the consensus estimate of $3.37 billion. During the same period in the prior year, the company posted $0.11 EPS. The company’s revenue was down 4.5% compared to the same quarter last year. As a group, research analysts anticipate that Estée Lauder Companies will post 2.95 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Estée Lauder Companies news, Director Charlene Barshefsky sold 3,437 shares of the business’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $91.93, for a total transaction of $315,963.41. Following the sale, the director now directly owns 49,800 shares in the company, valued at approximately $4,578,114. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Estée Lauder Companies news, Director Lynn Forester sold 3,890 shares of Estée Lauder Companies stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $93.61, for a total value of $364,142.90. Following the completion of the sale, the director now directly owns 15,209 shares in the company, valued at $1,423,714.49. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Charlene Barshefsky sold 3,437 shares of the company’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $91.93, for a total transaction of $315,963.41. Following the transaction, the director now owns 49,800 shares of the company’s stock, valued at approximately $4,578,114. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 12.78% of the stock is owned by company insiders.
Institutional Trading of Estée Lauder Companies
A number of hedge funds have recently modified their holdings of EL. Marshall Wace LLP lifted its holdings in Estée Lauder Companies by 3,065.6% during the 2nd quarter. Marshall Wace LLP now owns 1,983,083 shares of the company’s stock valued at $211,000,000 after purchasing an additional 1,920,439 shares during the last quarter. Vanguard Group Inc. grew its position in Estée Lauder Companies by 6.4% in the first quarter. Vanguard Group Inc. now owns 20,686,550 shares of the company’s stock valued at $3,188,832,000 after acquiring an additional 1,250,555 shares during the last quarter. Van ECK Associates Corp grew its holdings in shares of Estée Lauder Companies by 36.4% during the third quarter. Van ECK Associates Corp now owns 4,041,911 shares of the company’s stock worth $402,938,000 after purchasing an additional 1,078,926 shares during the last quarter. Independent Franchise Partners LLP lifted its stake in shares of Estée Lauder Companies by 44.4% in the second quarter. Independent Franchise Partners LLP now owns 3,466,048 shares of the company’s stock worth $368,788,000 after acquiring an additional 1,066,320 shares during the period. Finally, Swedbank AB acquired a new position in shares of Estée Lauder Companies in the first quarter worth approximately $82,664,000. 55.15% of the stock is currently owned by institutional investors and hedge funds.
Estée Lauder Companies Company Profile
The Estée Lauder Companies Inc manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. It offers skin care products, including moisturizers, serums, cleansers, toners, body care, exfoliators, acne care and oil correctors, facial masks, and sun care products; and makeup products, such as lipsticks, lip glosses, mascaras, foundations, eyeshadows, and powders, as well as compacts, brushes, and other makeup tools.
See Also
- Five stocks we like better than Estée Lauder Companies
- Stock Market Sectors: What Are They and How Many Are There?
- Intel: Is Now the Time to Be Brave?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Estée Lauder Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Estée Lauder Companies and related companies with MarketBeat.com's FREE daily email newsletter.